Source: Health Canada shortage reports · Updated Oct 27, 2026
Dapagliflozin has no current shortage reported in Canada. It has been in shortage before; the history is below.
An SGLT2 inhibitor used to lower blood sugar in type 2 diabetes and to treat heart failure.
Products affected
0 / 11
Reports on file
25
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Discontinued
GLN-DAPAGLIFLOZIN
5MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02519852
Discontinued
GLN-DAPAGLIFLOZIN
10MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02519860
Resolved
GLN-DAPAGLIFLOZIN
5MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02519852 · ended Sep 29, 2026 · Disruption of the manufacture of the drug.
Resolved
GLN-DAPAGLIFLOZIN
10MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02519860 · ended Sep 29, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-DAPAGLIFLOZIN
5MG · TABLET · APOTEX INC
DIN 02527189 · ended May 1, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-DAPAGLIFLOZIN
10MG · TABLET · APOTEX INC
DIN 02527197 · ended Jul 24, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-DAPAGLIFLOZIN
10MG · TABLET · APOTEX INC
DIN 02527197 · ended May 22, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP DAPAGLIFLOZIN
10MG · TABLET · JAMP PHARMA CORPORATION
DIN 02531372 · ended Apr 7, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-DAPAGLIFLOZIN
10MG · TABLET · APOTEX INC
DIN 02527197 · ended Nov 27, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ DAPAGLIFLOZIN
10MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02518740 · ended May 26, 2025 · Delay in shipping of the drug.
Resolved
PMS-DAPAGLIFLOZIN
5MG · TABLET · PHARMASCIENCE INC
DIN 02531550 · ended Feb 20, 2025 · Disruption of the manufacture of the drug.
Resolved
AURO-DAPAGLIFLOZIN
5MG · TABLET · AURO PHARMA INC
DIN 02531402 · ended Jan 31, 2025 · Demand increase for the drug.
Showing 12 of 25 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Dapagliflozin. Health Canada has 25 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Dapagliflozin is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BK).
Recent changes
Oct 27, 2026
Shortage resolved
Oct 27, 2026
Shortage resolved
Oct 27, 2026
Shortage resolved
Oct 27, 2026
Shortage resolved
Oct 27, 2026
Status changed
Oct 27, 2026
Status changed
Sep 29, 2026
Estimated end date moved earlier : null → Sep 30, 2026
Sep 29, 2026
New report filed
Sep 29, 2026
New report filed
Sep 29, 2026
Estimated end date moved earlier : null → Sep 30, 2026
Common questions
What is Dapagliflozin used for?
An SGLT2 inhibitor used to lower blood sugar in type 2 diabetes and to treat heart failure.
When will Dapagliflozin be back in stock in Canada?
Dapagliflozin has no active shortage; supply is normal per Health Canada reports.
Why is Dapagliflozin in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.